Y. Zhufeng

Metagenome-wide association study of gut microbiome features for myositis

Z. Li, J. Xu, Y. Li, 2021, medRxiv.

Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study

Y. Zhufeng, M. Miao, Jing He, 2022, Frontiers in Cellular and Infection Microbiology.

Therapeutic potential of targeting Tfr/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study

Y. Zhufeng, M. Miao, Ruiling Feng, 2021, Arthritis Research & Therapy.

Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis

Yanan Chu, Jun Yu, Y. Zhufeng, 2022, Science advances.

Therapeutic potential of targeting Tfr/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study

Y. Zhufeng, M. Miao, Ruiling Feng, 2021, Arthritis Research & Therapy.

The composition and function profile of the gut microbiota of patients with primary Sjögren’s syndrome

Fang Wang, Y. Zhufeng, Yongjing Cheng, 2023, Clinical Rheumatology.